Marina Biotech Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.94 |
Market Cap |
$4.92 B |
Shares Outstanding |
329.01 M |
Public Float |
190.26 M |
Address |
200 Technology Square Cambridge Massachusetts 02139 United States |
Employees | - |
Website | http://www.modernatx.com |
Updated | 07/08/2019 |
Marina Biotech, Inc. is a biotechnology company, which is engages in the discovery, development, and commercialization of drug therapeutics for hypertension. It offers Perstalia, which contains perindopril arginine, an angiotensin converting enzyme inhibitor, and amlodipine, a dihydropyridine calcium channel blocker, and is indicated for the treatment of hypertension. The company was founded on September 23, 1983 and is headquartered in City of Industry, CA. |